All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
REGN real return snapshot: after CPI-U inflation, REGN returned +34.32% over the past year and −1.25% YTD, with dividends reinvested. Since Apr. 2, 1991, REGN is up +1,411.65% in real purchasing-power return, or +7.94%/yr, and is currently −38.05% below its real total-return high on Aug. 27, 2024.
Data ending Fri Oct. 16, 2026
| Tue 1991-04-02💬 to Fri 2026-10-16 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| REGN × |
+1,411.65%
+7.94%/yr |
+14.20%/yr
R2=0.765 |
||||
| Regeneron Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Tue 1991-04-02💬 to Fri 2026-10-16 |
Start
Value |
End
Value |
|---|---|---|
| REGN × |
$10,000.00
1991-04-02 |
$151,164.88
2026-10-16 |
| YTD | YoY | |
|---|---|---|
| REGN × | −1.25% | +34.32% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| REGN × |
−38.05%
on 2026-10-16 from 2024-08-27 peak |
−92.82%
on 2005-04-14 from 2000-02-29 peak |
| Period ending Fri 2026-10-16 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| REGN × | +34.32% |
−25.97% −13.96%/yr |
−13.73% −4.80%/yr |
+17.74% +3.32%/yr |
+53.72% +4.39%/yr |
| Year | REGN |
|---|---|
| 2026 (YTD) | −1.25% |
| 2025 | +6.12% |
| 2024 | −21.17% |
| 2023 | +17.79% |
| 2022 | +7.31% |
| 2021 | +22.13% |
| 2020 | +26.94% |
| 2019 | −1.72% |
| 2018 | −2.51% |
| 2017 | +0.30% |
| 2016 | −33.75% |
| 2015 | +31.36% |
| 2014 | +47.93% |
| 2013 | +58.51% |
| 2012 | +203.37% |
| 2011 | +63.97% |
| 2010 | +33.77% |
| 2009 | +28.21% |
| 2008 | −24.04% |
| 2007 | +15.60% |
| 2006 | +23.13% |
| 2005 | +66.92% |
| 2004 | −39.36% |
| 2003 | −22.00% |
| 2002 | −35.79% |
| 2001 | −21.37% |
| 2000 | +167.52% |
| 1999 | +68.36% |
| 1998 | −15.23% |
| 1997 | −47.79% |
| 1996 | +22.41% |
| 1995 | +314.45% |
| 1994 | −81.15% |
| 1993 | +25.71% |
| 1992 | −35.66% |
| 1991 | −16.00% |
